Efficacy of interferon alpha in the treatment of refractory and sight threatening uveitis: a retrospective monocentric study of 45 patients (Q35763133)

From Wikidata

Jump to navigation Jump to search

scientific article published on 18 October 2006

edit

Language	Label	Description	Also known as
English	Efficacy of interferon alpha in the treatment of refractory and sight threatening uveitis: a retrospective monocentric study of 45 patients	scientific article published on 18 October 2006

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17050581

retrieved

10 August 2017

title

Efficacy of interferon alpha in the treatment of refractory and sight threatening uveitis: a retrospective monocentric study of 45 patients (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17050581

retrieved

10 August 2017

main subject

uveitis

1 reference

based on heuristic

inferred from title

author

Jean-Charles Piette

series ordinal

10

object named as

Jean-Charles Piette

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17050581

retrieved

10 August 2017

Nathalie Cassoux

series ordinal

5

object named as

Nathalie Cassoux

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17050581

retrieved

10 August 2017

author name string

Bahram Bodaghi

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17050581

retrieved

10 August 2017

Gael Gendron

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17050581

retrieved

10 August 2017

Bertrand Wechsler

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17050581

retrieved

10 August 2017

Céline Terrada

series ordinal

4

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17050581

retrieved

10 August 2017

Du Le Thi Huong

series ordinal

6

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17050581

retrieved

10 August 2017

Claire Lemaitre

series ordinal

7

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17050581

retrieved

10 August 2017

Christine Fradeau

series ordinal

8

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17050581

retrieved

10 August 2017

Phuc LeHoang

series ordinal

9

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17050581

retrieved

10 August 2017

language of work or name

English

0 references

publication date

18 October 2006

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17050581

retrieved

10 August 2017

published in

British Journal of Ophthalmology

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17050581

retrieved

10 August 2017

volume

91

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17050581

retrieved

10 August 2017

issue

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17050581

retrieved

10 August 2017

page(s)

335-339

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17050581

retrieved

10 August 2017

cites work

Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1857681

retrieved

2 October 2017

Interferon alpha-2a treatment for serpiginous choroiditis

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1857681

retrieved

2 October 2017

Immunosuppression for posterior uveitis

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1857681

retrieved

2 October 2017

Infliximab in refractory uveitis due to Behçet's disease

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1857681

retrieved

2 October 2017

The use of interferon alpha in Behçet disease: review of the literature

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1857681

retrieved

2 October 2017

Human recombinant interferon alfa-2a for the treatment of Behçet's disease with sight threatening posterior or panuveitis

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1857681

retrieved

2 October 2017

Interferon alfa combined with azathioprine for the uveitis of Behçet's disease: an open study

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1857681

retrieved

2 October 2017

Interferon alfa-2a in the treatment of Behçet disease: a randomized placebo-controlled and double-blind study

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1857681

retrieved

2 October 2017

Efficacy of interferon alfa-2a in severe and refractory uveitis associated with Behçet's disease

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1857681

retrieved

2 October 2017

Treatment of ocular symptoms of Behçet's disease with interferon alpha 2a: a pilot study

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1857681

retrieved

2 October 2017

Bone marrow hypoplasia and fibrosis following interferon treatment.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1857681

retrieved

2 October 2017

Clinical toxicity of interferons in cancer patients: a review

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1857681

retrieved

2 October 2017

Efficacy of interferon-alpha for the treatment of Kaposi's sarcoma herpesvirus-associated uveitis.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1857681

retrieved

25 September 2018

A prospective trial of infliximab therapy for refractory uveitis: preliminary safety and efficacy outcomes.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1857681

retrieved

25 September 2018

Uveitis in Behçet disease: an analysis of 880 patients.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1857681

retrieved

25 September 2018

Efficacy, safety, and pharmacokinetics of multiple administration of infliximab in Behçet's disease with refractory uveoretinitis

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1857681

retrieved

25 September 2018

Rescue of interferon induced bone marrow aplasia in a patient with chronic myeloid leukemia by allogeneic bone marrow transplant

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1857681

retrieved

25 September 2018

Interferon alfa-2a in the treatment of ocular Adamantiades-Behçet's disease

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1857681

retrieved

25 September 2018

Infliximab in the treatment of refractory posterior uveitis

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1857681

retrieved

25 September 2018

Familial recurrent bilateral panuveitis: efficiency of alpha interferon

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1857681

retrieved

25 September 2018

Posterior segment complications in patients with hepatitis C treated with interferon and ribavirin

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1857681

retrieved

25 September 2018

[Interferons and Behçet's disease].

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1857681

retrieved

25 September 2018

Visual loss during interferon-alpha therapy in hepatitis C virus infection

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1857681

retrieved

25 September 2018

Revised diagnostic criteria for Vogt-Koyanagi-Harada disease: report of an international committee on nomenclature

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1857681

retrieved

25 September 2018

Standardization of vitreal inflammatory activity in intermediate and posterior uveitis

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/17050581

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Results of interferon-alfa therapy in patients with Behçet uveitis

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/17050581

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

International Uveitis Study Group recommendations for the evaluation of intraocular inflammatory disease

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/17050581

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Criteria for diagnosis of Behçet's disease. International Study Group for Behçet's Disease

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/17050581

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interferon-alpha 2b for refractory ocular Behçet's disease

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/17050581

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Anterior Ischemic Optic Neuropathy Secondary to Interferon Alfa

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/17050581

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interferon alpha for ocular Behçet's disease

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/17050581

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Natural interferon therapy: optic nerve ischemic damage?

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/17050581

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chronic severe uveitis: etiology and visual outcome in 927 patients from a single center

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/17050581

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Influence of interferon-alpha on lymphocyte subpopulations in Behçet's disease

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/17050581

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The effect of anti-tumour necrosis factor alpha (infliximab) on sight-threatening uveitis in a patient with Behçet's disease

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/17050581

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Influence of human recombinant interferon- 2a (rhIFN- 2a) on altered lymphocyte subpopulations and monocytes in Behcet's disease

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/17050581

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Infliximab for chronic cystoid macular edema associated with uveitis

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/17050581

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of Adamantiades-Behçet disease with systemic interferon alfa

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/17050581

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interferon-alpha treatment of Behçet's disease

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/17050581

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Severe loss of vision during adjuvant interferon alfa-2b treatment for malignant melanoma

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/17050581

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interferon-a (IFN-a) application versus tumor necrosis factor-a antagonism for ocular Behçet's disease: focusing more on IFN

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/17050581

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

DOI

10.1136/BJO.2006.101550

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17050581

retrieved

10 August 2017

Fatcat ID

release_rb2ujb3b6bdi7ipuhwjo3oic5u

1 reference

stated in

Fatcat

reference URL

https://api.fatcat.wiki/v0/release/rb2ujb3b6bdi7ipuhwjo3oic5u

retrieved

24 November 2022

based on heuristic

mapped directly with Wikidata item

PMC publication ID

1857681

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17050581

retrieved

10 August 2017

PubMed publication ID

17050581

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17050581

retrieved

10 August 2017

ResearchGate publication ID

6744383

0 references

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35763133&oldid=1844307168"